QT
MRNA icon

Quantbot Technologies’s Moderna MRNA Stock Holding History

Quantbot Technologies’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$785K Buy
+11,211
New +$580K 0.03% 740
2026
Q1 		– Sell
-29,903
Closed -$882K – 1998
2025
Q4 		$882K Buy
29,903
+5,530
+23% +$150K 0.03% 723
2025
Q3 		$630K Sell
24,373
-34,481
-59% -$962K 0.02% 936
2025
Q2 		$1.62M Buy
+58,854
New +$1.55M 0.04% 601
2025
Q1 		– Sell
-9,307
Closed -$387K – 1731
2024
Q4 		$387K Buy
9,307
+7,066
+315% +$338K 0.01% 895
2024
Q3 		$150K Buy
+2,241
New +$206K 0.01% 1083
2023
Q3 		– Sell
-1,173
Closed -$143K – 1807
2023
Q2 		$143K Sell
1,173
-380
-24% -$50.7K 0.01% 1078
2023
Q1 		$239K Buy
+1,553
New +$256K 0.02% 849
2022
Q3 		– Sell
-1,921
Closed -$274K – 1901
2022
Q2 		$274K Buy
+1,921
New +$275K 0.03% 799
2021
Q3 		– Sell
-3,352
Closed -$787K – 1753
2021
Q2 		$787K Sell
3,352
-5,415
-62% -$968K 0.06% 426
2021
Q1 		$1.15M Buy
+8,767
New +$1.27M 0.11% 263
2020
Q4 		– Sell
-3,055
Closed -$216K – 1536
2020
Q3 		$216K Buy
+3,055
New +$213K 0.02% 566
2019
Q3 		– Sell
-15,500
Closed -$226K – 1451
2019
Q2 		$226K Buy
+15,500
New +$333K 0.02% 560

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Quantbot Technologies's MRNA Position: Q2 2026 in Review

Quantbot Technologies opened a new position in Moderna (MRNA) in Q2 2026: 11,211 shares worth $785K. The stake represents 0.03% of the portfolio and ranks #740 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in MRNA as recently as Q4 2025.

Quantbot Technologies first reported a position in MRNA in Q2 2019 and has held it in 13 quarters since. The position peaked at $1.62M in Q2 2025. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Quantbot Technologies held 11,211 shares of Moderna worth $785K as of Q2 2026.
  • Moderna was a new Quantbot Technologies position in Q2 2026.
  • Moderna made up 0.03% of Quantbot Technologies's portfolio in Q2 2026, its #740 holding.
  • Quantbot Technologies first reported a position in Moderna in Q2 2019 and has held it in 13 quarters since.
  • Quantbot Technologies's Moderna position peaked at $1.62M in Q2 2025.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.